Bleeding Higher With Standard-Dose DOACs in Nonvalvular A-Fib
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 16, 2023 -- For nursing home residents with nonvalvular atrial fibrillation, the rate of bleeding is higher with standard- versus reduced-dose direct acting oral anticoagulants (DOACs), according to a study published online Nov. 6 in the Journal of the American Heart Association.
Kaleen N. Hayes, Pharm.D., Ph.D., from Brown University School of Public Health in Providence, Rhode Island, and colleagues conducted a retrospective cohort study using 2013 to 2017 U.S. Medicare claims linked to Minimum Data Set records. DOAC initiators (those receiving apixaban, dabigatran, or rivaroxaban) aged 65 years or older with nonvalvular atrial fibrillation residing in a nursing home were identified. Propensity scores were used to estimate inverse-probability of treatment weights for DOAC dose.
Overall, 48 percent of the 21,878 DOAC initiators received reduced dosing. The researchers found that standard dosing was associated with a higher rate of bleeding after estimating inverse probability of treatment weights (hazard ratio, 1.18; 9.4 versus 8.0 events per 100 person-years). The highest rates of bleeding were seen in association with standard-dose therapy for those older than 80 years (9.1 versus 6.7 events per 100 person-years) and with a body mass index <30 kg/m2 (9.4 versus 7.4 events per 100 person-years). No association was seen for dosing with mortality or thrombotic events.
"Given the potential harms and unclear benefits of standard DOAC dosing, our results support the use of reduced-dose DOACs for many older adults with multiple chronic medical conditions," coauthor Sarah Berry, M.D., M.P.H., of Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research in Boston, said in a statement.
Two authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Fish Oil Beneficial for Reducing Risk for Cardiovascular Disease Progression
WEDNESDAY, May 22, 2024 -- The role of regular use of fish oil supplements varies for people with and without cardiovascular disease, according to a study published online May 21...
Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib
WEDNESDAY, May 22, 2024 -- Clinical outcomes are excellent with use of radiofrequency (RF) catheter ablation (CA) for paroxysmal atrial fibrillation (PAF), according to a study...
Deep Learning Model Using Transthoracic Echocardiograms Can ID A-Fib
TUESDAY, May 14, 2024 -- A deep learning model using transthoracic echocardiograms (TTEs) can predict patients with active or occult atrial fibrillation (AF), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.